iSpecimen Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
iSpecimen Inc. (ISPC) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 369 shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2025-08-14
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-06-30 was 277.00 shares, a 98.34% decline year-over-year.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-03-31 was 92.00 shares, a 99.15% decline year-over-year.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2024-12-31 was 1.04K shares, a 69.29% decline year-over-year.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2024-09-30 was -25.51K shares, a 188.59% decline year-over-year.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2023 was 65.22K shares, a 18.79% decline from fiscal 2022.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2022 was 80.31K shares, a 1387.31% increase from fiscal 2021.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2021 was 5.40K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | 277.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 369.00 shares 10-Q · filed 2025-08-14 | 1.41K shares derived: sum of 3 quarters · filed 2025-08-14 | -24.10K shares derived: sum of 4 quarters · filed 2025-08-14 | |
| 2025-03-31 | 92.00 shares 10-Q · filed 2025-05-19 | 1.13K shares derived: sum of 2 quarters · filed 2025-08-14 | -24.38K shares derived: sum of 3 quarters · filed 2025-08-14 | -7.70K shares derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-12-31 | 1.04K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2025-08-14 | -24.47K shares derived: sum of 2 quarters · filed 2025-08-14 | -7.79K shares derived: sum of 3 quarters · filed 2025-08-14 | 3.01K shares 10-Q · filed 2025-08-14 | |
| 2024-09-30 | -25.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -8.83K shares derived: sum of 2 quarters · filed 2024-11-07 | 1.97K shares 10-Q · filed 2024-11-07 | 5.36K shares derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-06-30 | 16.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 27.48K shares 10-Q · filed 2024-08-06 | 30.87K shares derived: sum of 3 quarters · filed 2024-08-06 | 59.66K shares derived: sum of 4 quarters · filed 2024-08-06 | |
| 2024-03-31 | 10.80K shares 10-Q · filed 2024-05-07 | 14.19K shares derived: sum of 2 quarters · filed 2024-05-07 | 42.98K shares derived: sum of 3 quarters · filed 2024-05-07 | 52.60K shares derived: sum of 4 quarters · filed 2024-05-07 | |
| 2023-12-31 | 3.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 32.19K shares derived: sum of 2 quarters · filed 2024-03-13 | 41.80K shares derived: sum of 3 quarters · filed 2024-03-13 | 65.22K shares 10-K · filed 2024-03-13 | |
| 2023-09-30 | 28.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 38.41K shares derived: sum of 2 quarters · filed 2023-11-02 | 61.83K shares 10-Q · filed 2023-11-02 | 103.38K shares derived: sum of 4 quarters · filed 2024-03-13 | |
| 2023-06-30 | 9.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | 33.03K shares 10-Q · filed 2023-08-02 | 74.59K shares derived: sum of 3 quarters · filed 2024-03-13 | 90.98K shares derived: sum of 4 quarters · filed 2024-03-13 | |
| 2023-03-31 | 23.42K shares 10-Q · filed 2023-05-04 | 64.97K shares derived: sum of 2 quarters · filed 2024-03-13 | 81.37K shares derived: sum of 3 quarters · filed 2024-03-13 | 101.48K shares derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-12-31 | 41.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 57.95K shares derived: sum of 2 quarters · filed 2024-03-13 | 78.06K shares derived: sum of 3 quarters · filed 2024-03-13 | 80.31K shares 10-K · filed 2024-03-13 | |
| 2022-09-30 | 16.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 36.51K shares derived: sum of 2 quarters · filed 2022-11-08 | 38.76K shares 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | 20.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 22.37K shares 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | 2.25K shares 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | 5.40K shares 10-K/A · filed 2023-03-30 | 2.70K shares 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |